Anti-Depressant Drug Seroxat
EDM number 1203 in 2002-03, proposed by Sandra Gidley on 13/05/2003.
That this House calls for the anti-depressant drug Seroxat to be withdrawn from use for new prescribing pending an urgent, fully independent review of its and other SSRI anti-depressants' safety, because of the extensive evidence of severe withdrawal reactions and an increased risk of suicide associated with it; and calls on the Medicines and Healthcare Products Regulation Agency in conducting the review to include people with experience of using Seroxat and to make full use of the consumer-based evidence and research available, such as that conducted by Panorama and Mind.
This motion has been signed by a total of 41 MPs.
Download raw data as csv or xml.